SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001551163-19-000126
Filing Date
2019-05-15
Accepted
2019-05-15 13:15:08
Documents
27
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 q-1finalvedgar3.htm 10-Q 339468
2 exhi31.1vedgar1.htm EX-31 6402
3 ex31.2vedgar1.htm EX-31 7403
4 exhibit32vedgar2.htm EX-32 2905
  Complete submission text file 0001551163-19-000126.txt   1038689

Data Files

Seq Description Document Type Size
5 bion-20190331.xml EX-101.INS 159624
6 bion-20190331.xsd EX-101.SCH 7585
7 bion-20190331_cal.xml EX-101.CAL 17492
8 bion-20190331_def.xml EX-101.DEF 5319
9 bion-20190331_lab.xml EX-101.LAB 60426
10 bion-20190331_pre.xml EX-101.PRE 45166
Mailing Address 21-2 CAMELLIA, 5 JALAN KERINCHI KUALA LUMPUR N8 59200
Business Address 21-2 CAMELLIA, 5 JALAN KERINCHI KUALA LUMPUR N8 59200 60122126512
BioNexus Gene Lab Coporation (Filer) CIK: 0001737523 (see all company filings)

IRS No.: 262124961 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-229399 | Film No.: 19826764
SIC: 8071 Services-Medical Laboratories
Assistant Director 9